AVXL Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own AVXL shares is 189, representing 32.04% of the company's common stock.

BANK OF NEW YORK MELLON CORP, in the last quarter, reduced its stake in AVXL by -6.42% restricting it's holding to 239.66 thousand shares of worth nearly $1.22M. MORGAN STANLEY also lessened -24.67% of the AVXL shares from its portfolio, reducing its holding to 340.63 thousand shares of worth $1.73M. SUSQUEHANNA INTERNATIONAL GROUP, LLP also shunned AVXL shares holding by -59.77% last quarter which brought its holding to 260.8 thousand shares worth $1.33M.

As per its latest 13F filing, LOS ANGELES CAPITAL MANAGEMENT LLC increased its stake in AVXL by 51.38% in the last quarter. The institutional holder raised its holding to 87.93 thousand shares having worth more than $447.57K. COMMONWEALTH EQUITY SERVICES, LLC also added 100% more shares of AVXL to its portfolio, raising its holding to 93.57 thousand shares of worth $476.00K. NUVEEN ASSET MANAGEMENT, LLC also increased its AVXL shares holding by 10.54% which brought its holding to 265.79 thousand shares worth $1.35M.

The insider with the most stakes in AVXL is Skarpelos Athanasios , at the company. Additionally, AVXL stock is highly held by President and CEO MISSLING CHRISTOPHER U and President COO Secretary Lalach Harvey among others.

Company executives, directors, and other insiders own 3.05% percent of Anavex Life Sciences Corp.'s stock. Within the last six months, there have been 0 transaction(s) in which AVXL insiders have sold stock, totaling 0 shares. Insiders that have sold shares include MISSLING CHRISTOPHER U, SKARPELOS ATHANASIOS, and BOENISCH SANDRA.

There have been 0 transaction(s) during the past 6-months in which Anavex Life Sciences Corp. insiders have bought stock, totalling 0 shares

Around 0 Anavex Life Sciences Corp. shares are held by insiders, which represents about 3.05% of AVXL stock.

AVXL , Skarpelos Athanasios holds the largest portfolio of the company's shares. AVXL shares owned by Skarpelos total nearly 1.31 million.

LOS ANGELES CAPITAL MANAGEMENT LLC is the largest institutional owner in AVXL which holds 87.93 thousand shares worth $447.57K or 0.11% of the total AVXL shares outstanding followed by COMMONWEALTH EQUITY SERVICES, LLC with ownership of 93.57 thousand shares representing 0.11% of the AVXL ownership. UBS ASSET MANAGEMENT AMERICAS INC is the third largest stakeholder with 96.92 thousand shares or 0.12% of the ownership worth more than $493.34K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the AVXL is concerned, it is a stock which is optionable.

Number of AVXL shares short is 19.69M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 84.82M shares of AVXL are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, AVXL has 82.21M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for AVXL is 10.82.